Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.92 USD | -1.00% | -11.43% | -11.90% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 28K | Sales 2025 * | 29K | Capitalization | 198M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -51M | EV / Sales 2024 * | 7,072 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6,828 x |
P/E ratio 2024 * |
-3.72
x | P/E ratio 2025 * |
-3.92
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.73% |
Latest transcript on INmune Bio, Inc.
1 day | -1.00% | ||
1 week | -11.43% | ||
Current month | -16.22% | ||
1 month | +3.55% | ||
3 months | -18.49% | ||
6 months | +34.97% | ||
Current year | -11.90% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 9.92 | -1.00% | 154,436 |
24-05-10 | 10.02 | -6.96% | 148,564 |
24-05-09 | 10.77 | +2.77% | 107,133 |
24-05-08 | 10.48 | -6.26% | 128,190 |
24-05-07 | 11.18 | -0.18% | 63,843 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.90% | 198M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- INMB Stock